Skip to Main Content

Author Details

Amar U Kishan
University of California los angeles
2008
240
29
PMIDPaper TitleJournal TitlePublished Year
37423774The Impact of Positron Emission Tomography Imaging and Tumor Molecular Profiling on Risk Stratification, Treatment Choice, and Oncological Outcomes of Patients with Primary or Relapsed Prostate Cancer: An International Collaborative Review of the Existing Literature.Eur Urol Oncol2024
37805372Bullseye or Tip of the Iceberg: Magnetic Resonance Imaging-visible Disease in Radiorecurrent Prostate Cancer.Eur Urol2024
37802226Long-Term Quality-of-Life Outcomes After Prostate Radiation Therapy With or Without High-Dose-Rate Brachytherapy Boost: Post Hoc Analysis of TROG 03.04 RADAR.Int J Radiat Oncol Biol Phys2024
37661040Stereotactic Body Radiation Therapy: A Radiosurgery Society Guide to the Treatment of Localized Prostate Cancer Illustrated by Challenging Cases.Pract Radiat Oncol2024
37516159Performance Analysis of a Radiation Oncology Educational Podcast.J Am Coll Radiol2024
38055353Dosimetric predictors for genitourinary toxicity in MR-guided stereotactic body radiation therapy (SBRT): Substructure with fraction-wise analysis.Med Phys2024
37875222Monitoring Intrafraction Motion of the Prostate During Radiation Therapy: Suggested Practice Points From a Focused Review.Pract Radiat Oncol2024
37924987Effect of Pelvic External Beam Radiation Therapy on Bone Mineral Density: A Secondary Analysis of a Phase 3 Randomized Controlled Trial.Int J Radiat Oncol Biol Phys2024
37871887Impact of Interfractional Bladder and Trigone Displacement and Deformation on Radiation Exposure and Subsequent Acute Genitourinary Toxicity: A Post Hoc Analysis of Patients Treated with Magnetic Resonance Imaging-Guided Prostate Stereotactic Body Radiation Therapy in a Phase 3 Randomized Trial.Int J Radiat Oncol Biol Phys2024
35058580Significant changes in macrophage and CD8 T cell densities in primary prostate tumors 2 weeks after SBRT.Prostate Cancer Prostatic Dis2023
37760626MRI-Guided Radiation Therapy for Prostate Cancer: The Next Frontier in Ultrahypofractionation.Cancers (Basel)2023
37802722Clinical Usefulness of Prostate-specific Membrane Antigen-ligand Positron Emission Tomography/Computed Tomography for the Detection of Prostate Cancer Biochemical Recurrence after Primary Radiation Therapy in Patients with Prostate-specific Antigen Below the Phoenix Threshold: Systematic Review and Meta-analysis.Clin Oncol (R Coll Radiol)2023
37950310Use of focal radiotherapy boost for prostate cancer: radiation oncologists' perspectives and perceived barriers to implementation.Radiat Oncol2023
37792009Association of PSA kinetics after testosterone recovery with subsequent recurrence: secondary analysis of a phase III randomized controlled trial.World J Urol2023
37650773Analytical HDR prostate brachytherapy planning with automatic catheter and isotope selection.Med Phys2023
37647496Selecting the optimal radiation modality in prostate cancer.Clin Adv Hematol Oncol2023
37646527Human factors in the clinical implementation of deep learning-based automated contouring of pelvic organs at risk for MRI-guided radiotherapy.Med Phys2023
37777738A randomized phase II trial of MR-guided prostate stereotactic body radiotherapy administered in 5 or 2 fractions for localized prostate cancer (FORT).BMC Cancer2023
37686668Prognostic Role of Dynamic Changes in Serological Markers in Metastatic Hormone Naïve Prostate Cancer.Cancers (Basel)2023
38039002Racial and Ethnic Disparities in Use of Novel Hormonal Therapy Agents in Patients With Prostate Cancer.JAMA Netw Open2023
37639648Biochemical Recurrence Surrogacy for Clinical Outcomes After Radiotherapy for Adenocarcinoma of the Prostate.J Clin Oncol2023
35790787Development and validation of a multivariable prognostic model in de novo metastatic castrate sensitive prostate cancer.Prostate Cancer Prostatic Dis2023
37060201A novel prostate cancer subtyping classifier based on luminal and basal phenotypes.Cancer2023
37182995Advances in MRI-Guided Radiation Therapy.Surg Oncol Clin N Am2023
37246070Contemporary Evaluation of Salvage Radiotherapy for Prostate Cancer: Radiotherapy Dose, Field Size, and Use of Hormone Therapy.Eur Urol2023
37141981High Recurrence for HPV-Positive Oropharyngeal Cancer With Neoadjuvant Radiation Therapy to Gross Disease Plus Immunotherapy: Analysis From a Prospective Phase Ib/II Clinical Trial.Int J Radiat Oncol Biol Phys2023
37438199Re: Dose-escalated Radiotherapy Alone or in Combination with Short-term Androgen Deprivation for Intermediate-risk Prostate Cancer: Results of a Phase III Multi-institutional Trial.Eur Urol2023
37071764Implications of metastatic stage at presentation in docetaxel naïve metastatic castrate resistant prostate cancer.Prostate2023
37003878Determinants of widespread metastases and of metastatic tropism in patients with prostate cancer: A genomic analysis of primary and metastatic tumors.Urol Oncol2023
36966268Race-dependent association of clinical trial participation with improved outcomes for high-risk prostate cancer patients treated in the modern era.Prostate Cancer Prostatic Dis2023
36857621Reply to A. Abner et al.J Clin Oncol2023
36723856Multimodality Therapies for Localized Prostate Cancer.Curr Oncol Rep2023
36880064Application of a genetic signature of late GU toxicity in SCIMITAR, a Post-op SBRT trial.Clin Transl Radiat Oncol2023
36717727Mask R-CNN assisted 2.5D object detection pipeline of <sup>68</sup>Ga-PSMA-11 PET/CT-positive metastatic pelvic lymph node after radical prostatectomy from solely CT imaging.Sci Rep2023
36610996A polygenic two-hit hypothesis for prostate cancer.J Natl Cancer Inst2023
36870853Transcriptomic Heterogeneity in High-risk Prostate Cancer and Implications for Extraprostatic Disease at Presentation on Prostate-specific Membrane Antigen Positron Emission Tomography.Eur Urol Oncol2023
36739178Early Safety and Efficacy Profile of Homogeneously Dosed Salvage Stereotactic Body Radiotherapy (SBRT) for Intraprostatic Recurrences After Low Dose Rate (LDR) Brachytherapy.Clin Genitourin Cancer2023
36934894The role of adaptive planning in margin-reduced, MRI-guided stereotactic body radiotherapy to the prostate bed following radical prostatectomy: Post-hoc analysis of a phase II clinical trial.Radiother Oncol2023
36532603Experience of Telemedicine Visits in Radiation Oncology During the COVID-19 Pandemic: A US National Survey and Lessons Learned for Incorporating Telemedicine Post-COVID-19.Adv Radiat Oncol2023
36797449LUNAR: a randomized Phase 2 study of <sup>177</sup> Lutetium-PSMA Neoadjuvant to Ablative Radiotherapy for Oligorecurrent Prostate Cancer (clinical trial protocol).BJU Int2023
36633877Magnetic Resonance Imaging-Guided vs Computed Tomography-Guided Stereotactic Body Radiotherapy for Prostate Cancer: The MIRAGE Randomized Clinical Trial.JAMA Oncol2023
36456467Oligometastatic Hormone-Sensitive Prostate Cancer. Why Radiotherapy?Clin Genitourin Cancer2023
36759200[68]Ga-PSMA PET/CT-Based Atlas for Prostate Bed Recurrence After Radical Prostatectomy: Clinical Implications for Salvage Radiation Therapy Contouring Guidelines.J Nucl Med2023
36894488Effect of Prior Local Therapy on Response to First-line Androgen Receptor Axis Targeted Therapy in Metastatic Castrate-resistant Prostate Cancer: A Secondary Analysis of the COU-AA-302 Trial.Eur Urol2023
36863416Patterns of Failure in Men With Radiorecurrent Prostate Cancer: A Post Hoc Analysis of 3 Prospective Gallium 68 Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography Imaging Trials.Int J Radiat Oncol Biol Phys2023
36757690Hyaluronic Acid Spacer for Hypofractionated Prostate Radiation Therapy: A Randomized Clinical Trial.JAMA Oncol2023
36179990External Beam Radiation Therapy With or Without Brachytherapy Boost in Men With Very-High-Risk Prostate Cancer: A Large Multicenter International Consortium Analysis.Int J Radiat Oncol Biol Phys2023
36106703Fully automated segmentation of prostatic urethra for MR-guided radiation therapy.Med Phys2023
36269935Sequencing of Androgen-Deprivation Therapy of Short Duration With Radiotherapy for Nonmetastatic Prostate Cancer (SANDSTORM): A Pooled Analysis of 12 Randomized Trials.J Clin Oncol2023
36097167Association of dynamic change in patient-reported pain with survival in metastatic castrate sensitive prostate cancer-exploratory analysis of LATITUDE study.Prostate Cancer Prostatic Dis2023
  • 1 - 50 of 240

Recommended Authors

Kristina Commisso
University Health Network
Career Start Year 2016
Number of shared co-authors 4
Niluja Thiruthaneeswaran
The University of Sydney, Westmead Hospital
Career Start Year 2014
Number of shared co-authors 10
R Jeffrey Karnes
Mayo Clinic
Career Start Year 2013
Number of shared co-authors 35
Andrew Warner
Western University and London Regional Cancer Program
Career Start Year 2013
Number of shared co-authors 7
Giorgio Gandaglia
IRCCS San Raffaele Scientific Institute, Italy Vita-Salute San Raffaele University
Career Start Year 2012
Number of shared co-authors 41
Devin N Patel
university of california san diego School of Medicine
Career Start Year 2011
Number of shared co-authors 5
Joseph Sia
Peter MacCallum Cancer Centre, University of Melbourne
Career Start Year 2011
Number of shared co-authors 1
Xin Pei
Memorial Sloan Kettering Cancer Center
Career Start Year 2010
Number of shared co-authors 6
Izak Faiena
Columbia University Medical Center
Career Start Year 2010
Number of shared co-authors 8
Suneil Jain
Cancer Centre Belfast City Hospital, Queen's University Belfast
Career Start Year 2008
Number of shared co-authors 17
Jure Murgic
University Hospital Center Sestre Milosrdnice
Career Start Year 2008
Number of shared co-authors 13
John Thoms
Memorial University
Career Start Year 2008
Number of shared co-authors 8
Alastair D Lamb
University of Oxford
Career Start Year 2007
Number of shared co-authors 17
Stephanie Peeters
University of Liege, Centre Hospitalier Universitaire de Liege
Career Start Year 2005
Number of shared co-authors 0
Nicholas van As
The Institute of Cancer Research, Royal Marsden NHS Foundation Trust
Career Start Year 2005
Number of shared co-authors 11
Scott T Tagawa
Meyer Cancer Center, Weill Cornell Medicine-NewYork Presbyterian Hospital
Career Start Year 2003
Number of shared co-authors 32
Andrew K Lee
Texas Center for Proton Therapy
Career Start Year 2001
Number of shared co-authors 6
Amit Bahl
University Hospitals Bristol and Weston NHS Foundation Trust
Career Start Year 2001
Number of shared co-authors 13
Zhigang Zhang
Memorial Sloan Kettering Cancer Center
Career Start Year 2001
Number of shared co-authors 9
David A Palma
University of Western Ontario
Career Start Year 2000
Number of shared co-authors 13
Drew Moghanaki
University of California Los Angeles
Career Start Year 2000
Number of shared co-authors 27
Michael J Morris
Memorial Sloan Kettering Cancer Center
Career Start Year 1999
Number of shared co-authors 44
Evan Y Yu
University of Washington and Fred Hutchinson Cancer Research Center
Career Start Year 1997
Number of shared co-authors 45
Eric Vigneault
Centre Hospitalier Universitaire de Quebec
Career Start Year 1997
Number of shared co-authors 23
Vincent Khoo
The Royal Marsden NHS Foundation Trust and Institute of Cancer Research
Career Start Year 1996
Number of shared co-authors 24
Inge M van Oort
Radboud University Medical Center
Career Start Year 1995
Number of shared co-authors 28
Glenn Bauman
Western University and London Regional Cancer Program
Career Start Year 1994
Number of shared co-authors 8
Markus Graefen
University Hospital Frankfurt, Goethe University Frankfurt am Main
Career Start Year 1993
Number of shared co-authors 33
Andrzej Niemierko
Massachusetts General Hospital
Career Start Year 1982
Number of shared co-authors 19
Andre Konski
Chester County Hospital
Career Start Year 1982
Number of shared co-authors 15

Collaborators

Michael L Steinberg
University of California los angeles
Co-authored papers 99
Nicholas G Nickols
University of California, Veteran Affairs Greater Los Angeles Healthcare System
Co-authored papers 61
Daniel E Spratt
University Hospitals Seidman Cancer Center, Case Western Reserve University
Co-authored papers 55
Minsong Cao
University of California Los Angeles
Co-authored papers 55
Patrick A Kupelian
university of california los angeles Medical Center
Co-authored papers 40
Robert E Reiter
David Geffen School of Medicine at university of california los angeles
Co-authored papers 38
Christopher R King
University of California los angeles
Co-authored papers 38
Matthew B Rettig
David Geffen School of Medicine, University of California los angeles
Co-authored papers 38
Ting Martin Ma
University of Washington
Co-authored papers 30
Felix Y Feng
UCSF Medical Center-Mount Zion
Co-authored papers 28
Nicholas G Zaorsky
University Hospitals Seidman Cancer Centre, Cleveland Medical Centre
Co-authored papers 23
Robert T Dess
University of Michigan ann arbor
Co-authored papers 21
Daniel A Low
University of California los angeles
Co-authored papers 21
Paul L Nguyen
Brigham and Women's Hospital and Dana Farber Cancer Institute, Harvard Medical School
Co-authored papers 21
Jeremie Calais
university of california los angeles
Co-authored papers 18
Yingli Yang
Ruijin Hospital
Co-authored papers 17
Phuoc T Tran
University of Maryland School of Medicine
Co-authored papers 17
Brandon A Mahal
Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine
Co-authored papers 16
Tahmineh Romero
David Geffen School of Medicine at university of california los angeles
Co-authored papers 16
David Jeffrey Demanes
University of California los angeles
Co-authored papers 15
Luca F Valle
University of California los angeles
Co-authored papers 15
David Elashoff
David Geffen School of Medicine at University of California los angeles
Co-authored papers 15
Michael Xiang
University of California los angeles
Co-authored papers 13
Fang-I Chu
David Geffen School of Medicine, University of California los angeles
Co-authored papers 13
Howard M Sandler
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers 13
Paul C Boutros
University of California los angeles
Co-authored papers 13
Thomas M Pisansky
Mayo Clinic
Co-authored papers 13
William C Jackson
University of Michigan ann arbor
Co-authored papers 12
Wolfgang Lilleby
Oslo University Hospital
Co-authored papers 12
David Shabsovich
university of california los angeles Medical Center
Co-authored papers 12
Release 1.2